NO20080501L - Kinolinderivater som antibakterielle midler - Google Patents
Kinolinderivater som antibakterielle midlerInfo
- Publication number
- NO20080501L NO20080501L NO20080501A NO20080501A NO20080501L NO 20080501 L NO20080501 L NO 20080501L NO 20080501 A NO20080501 A NO 20080501A NO 20080501 A NO20080501 A NO 20080501A NO 20080501 L NO20080501 L NO 20080501L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- hydrogen
- het
- hydroxy
- compound
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 8
- 229910052739 hydrogen Inorganic materials 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000004414 alkyl thio group Chemical group 0.000 abstract 2
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 2
- -1 cyano, hydroxy Chemical group 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 206010062207 Mycobacterial infection Diseases 0.000 abstract 1
- 125000000815 N-oxide group Chemical group 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000006350 alkyl thio alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000027531 mycobacterial infectious disease Diseases 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Anvendelse av en forbindelse for fremstilling av et medikament for behandling av en bakteriell infeksjon, forutsatt at den bakterielle infeksjon er noe annet enn en mykobakteriell infeksjon, hvor nevnte forbindelse er en forbindelse med formel (Ia) eller (Ib) et farmasøytisk akseptabelt syre- eller baseaddisjonssalt derav, en stereokjemisk isomer form derav, en tautomer form derav eller en N-oksidform derav, hvori Rer hydrogen, halogen, halogenalkyl, cyano, hydroksy, Ar, Het, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; p er 1, 2, 3 eller 4; Rer hydrogen, hydroksy, merkapto, alkyloksy, alkyloksyalkyloksy, alkyltio, mono- eller di(alkyl)amino eller et radikal med formel. Rer alkyl, Ar, Ar-alkyl, Het eller Het-alkyl; q er 1,2 eller 3; R og R er hydrogen, alkyl eller benzyl; eller R og Rsammen og iberegnet N-atomet som de er bundet til, kan danne en ring; Rer hydrogen, halogen, halogenalkyl, hydroksy, Ar, alkyl, alkyloksy, alkyltio, alkyloksyalkyl, alkyltioalkyl, Ar-alkyl eller di(Ar)alkyl; eller to nærliggende R6-radikaler kan være tatt sammen og danner et toverdig radikal med formel -CH=CH-CH=CH-; r er 1, 2, 3, 4 eller 5; Rer hydrogen, alkyl, Ar eller Het; Rer hydrogen eller alkyl; Rer okso; eller Rog Rsammen danner radikalet -CH=CH-N=.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105762 | 2005-06-28 | ||
| PCT/EP2006/063553 WO2007000435A1 (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20080501L true NO20080501L (no) | 2008-02-28 |
| NO342701B1 NO342701B1 (no) | 2018-07-09 |
Family
ID=34940244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080501A NO342701B1 (no) | 2005-06-28 | 2008-01-28 | Kinolinderivater som antibakterielle midler |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US8841321B2 (no) |
| EP (1) | EP1898914B1 (no) |
| JP (1) | JP5193858B2 (no) |
| KR (1) | KR101329585B1 (no) |
| CN (1) | CN101247811B (no) |
| AP (1) | AP2386A (no) |
| AR (1) | AR054626A1 (no) |
| AU (1) | AU2006263883B2 (no) |
| BR (1) | BRPI0612498A8 (no) |
| CA (1) | CA2612619C (no) |
| CY (1) | CY1113579T1 (no) |
| DK (1) | DK1898914T3 (no) |
| EA (1) | EA014423B1 (no) |
| ES (1) | ES2393203T3 (no) |
| HR (1) | HRP20120912T1 (no) |
| IL (1) | IL188393A0 (no) |
| JO (1) | JO2752B1 (no) |
| ME (1) | ME01484B (no) |
| MX (1) | MX2008000081A (no) |
| MY (1) | MY153291A (no) |
| NO (1) | NO342701B1 (no) |
| NZ (1) | NZ564379A (no) |
| PA (1) | PA8683801A1 (no) |
| PL (1) | PL1898914T3 (no) |
| PT (1) | PT1898914E (no) |
| RS (1) | RS52517B (no) |
| SI (1) | SI1898914T1 (no) |
| TW (1) | TWI387457B (no) |
| UA (1) | UA92175C2 (no) |
| WO (1) | WO2007000435A1 (no) |
| ZA (1) | ZA200711165B (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2970B1 (en) | 2006-12-06 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| EP2841425B1 (en) | 2012-04-27 | 2016-03-23 | Janssen Pharmaceutica, N.V. | Antibacterial quinoline derivatives |
| PT2841426T (pt) | 2012-04-27 | 2016-11-23 | Janssen Pharmaceutica Nv | Derivados de quinolina antibacterianos |
| CN107001272A (zh) | 2014-12-23 | 2017-08-01 | 阿尔比马尔公司 | 用于合成烷基化甲吡酮类似物的一步法 |
| CN106928139B (zh) * | 2017-05-08 | 2019-06-25 | 福建省微生物研究所 | 一种贝达喹啉杂质的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| EP1527050B1 (en) * | 2002-07-25 | 2010-04-07 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
| SI1675852T1 (sl) * | 2003-09-22 | 2009-06-30 | Janssen Pharmaceutica Nv | 7-amino alkilidenil-heterociklični kinoloni in naftiridoni |
| BRPI0510414B1 (pt) * | 2004-05-28 | 2022-04-05 | Janssen Pharmaceutica N.V. | Combinação e composição farmacêutica |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
| AP2547A (en) | 2005-06-28 | 2012-12-26 | Janssen Pharmaceutica Nv | Quinoline derivatives as antibacterial agents |
-
2006
- 2006-06-25 JO JO2006188A patent/JO2752B1/en active
- 2006-06-26 ME MEP-2012-127A patent/ME01484B/me unknown
- 2006-06-26 AU AU2006263883A patent/AU2006263883B2/en not_active Ceased
- 2006-06-26 NZ NZ564379A patent/NZ564379A/en not_active IP Right Cessation
- 2006-06-26 AP AP2008004303A patent/AP2386A/xx active
- 2006-06-26 KR KR1020087002107A patent/KR101329585B1/ko not_active Expired - Fee Related
- 2006-06-26 WO PCT/EP2006/063553 patent/WO2007000435A1/en not_active Ceased
- 2006-06-26 CN CN2006800310552A patent/CN101247811B/zh not_active Expired - Fee Related
- 2006-06-26 EP EP06763889A patent/EP1898914B1/en active Active
- 2006-06-26 EA EA200800154A patent/EA014423B1/ru unknown
- 2006-06-26 MX MX2008000081A patent/MX2008000081A/es active IP Right Grant
- 2006-06-26 JP JP2008518810A patent/JP5193858B2/ja not_active Expired - Fee Related
- 2006-06-26 RS RS20120480A patent/RS52517B/sr unknown
- 2006-06-26 SI SI200631468T patent/SI1898914T1/sl unknown
- 2006-06-26 CA CA2612619A patent/CA2612619C/en not_active Expired - Fee Related
- 2006-06-26 DK DK06763889.0T patent/DK1898914T3/da active
- 2006-06-26 PT PT06763889T patent/PT1898914E/pt unknown
- 2006-06-26 HR HRP20120912TT patent/HRP20120912T1/hr unknown
- 2006-06-26 US US11/993,145 patent/US8841321B2/en not_active Expired - Fee Related
- 2006-06-26 BR BRPI0612498A patent/BRPI0612498A8/pt not_active Application Discontinuation
- 2006-06-26 PL PL06763889T patent/PL1898914T3/pl unknown
- 2006-06-26 UA UAA200714927A patent/UA92175C2/ru unknown
- 2006-06-26 ES ES06763889T patent/ES2393203T3/es active Active
- 2006-06-27 MY MYPI20063044A patent/MY153291A/en unknown
- 2006-06-27 TW TW095123127A patent/TWI387457B/zh not_active IP Right Cessation
- 2006-06-28 AR ARP060102787A patent/AR054626A1/es unknown
- 2006-06-28 PA PA20068683801A patent/PA8683801A1/es unknown
-
2007
- 2007-12-20 ZA ZA2007/11165A patent/ZA200711165B/en unknown
- 2007-12-25 IL IL188393A patent/IL188393A0/en active IP Right Grant
-
2008
- 2008-01-28 NO NO20080501A patent/NO342701B1/no not_active IP Right Cessation
-
2012
- 2012-11-14 CY CY20121101090T patent/CY1113579T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080955L (no) | Kinolinderivater som antibakterielle midler | |
| NO20081026L (no) | Kinolinderivater som antibakterielle midler | |
| TW200716648A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
| NO20073823L (no) | Kinolinderivater for behandlingen av latent tuberkulose | |
| EA200970535A1 (ru) | Антибактериальные производные хинолина | |
| TW200738729A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
| EA200970534A1 (ru) | Антибактериальные производные хинолина | |
| NO20080499L (no) | Kinolinderivater som antibakterielle midler | |
| NO20080501L (no) | Kinolinderivater som antibakterielle midler | |
| NO20081068L (no) | Kinolinderivater som antibakterielle midler | |
| NO20080481L (no) | Kinolinderivater som antibakterielle midler | |
| EA200970536A1 (ru) | Антибактериальные хинолиновые производные | |
| JO2683B1 (en) | Quinoline antibacterial derivatives | |
| EA200500802A1 (ru) | Лечение латентного туберкулёза |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |